Where The American Data Privacy Protection Act Stands Today Lacks Significant Relevance to Medicine Right Now

Most health system, insurance, and life sciences stakeholders take compliance seriously. It’s still the wild west in software: image credit https://healthitsecurity.com/news/ocr-aims-to-improve-smaller-data-breach-investigation-process
Are penalties real deterrents or the paper tiger cost of doing business? It depends on how much your market segment banks on trust
As of July 21, 2022 a long road remains to deliver results in privacy protection to consumers. The red arrow is where we are now as of this date image credit: simhanaidu.blogspot.com
  1. Thousands of incredibly talented public affairs, lobbying, and PR professionals at several individual companies have already started flooding the market, media, and op eds with content. While most doctors are immune to propaganda, the latter is designed to and will have a yet to be determined impact on general public and investor sentiment.
  2. Entire ecosystems and their fans and followers have subsequently and will increasingly parrot talking points with and most often without context. Congratulations in advance for the successful messaging/parroting that will take place.
  3. There is for practical purposes no impact on medical technology since this primarily concerns software for consumers. We anticipate as inferred in the excerpt at the bottom of this post; that software for medical use will continue to be increasingly assigned risk informed classes and regulated.
For those of you who need “more” Image credit Burley Civics online https://sites.google.com/a/k12albemarle.org/8th-grade-civics-and-economics/course-content/unit-four---lawmaking-and-amendment-making-processes
In life sciences, it goes way beyond trust; you don’t even get to market a product unless you comply
This highest level, threat of criminal impacts is what causes market change. Regulating by Numbers: The Trend Towards Increasing Empiricism in Enforcement Reporting by Financial Regulators (2015) 9 Law and Financial Markets Review 260 — Scientific Figure on ResearchGate. Available from: https://www.researchgate.net/figure/Enforcement-of-directors-duties-in-Australian-corporate-law_fig8_292344591 [accessed 21 Jul, 2022]
Image credit: MEMS Journal https://www.memsjournal.com/2012/11/biomems-navigating-the-medical-device-fda-approval-process.html

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store